Open original FDA record ↗Recall record
- FDA identifier
- Z-0624-06
- Company in FDA record
- Abbott Health Products, Inc.
- FDA classification date
- Mar 15, 2006
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Patient results reported using calibrators made from new primary material may be falsely decreased by 5-8% compared to results using calibrators made from the previous primary material. An Important Product Information Letter with technical information regarding the Whole Blood Calibrators and Controls, implementing new internal reference standards was issued.
Source facts
- Action
- Abbott has recently implemented new internal reference standards for TDx/TDxFLx Cyclosporine monoclonal Whole Blood Calibrators and Controls. A change in performance is associated with the use of calibrator lots 1829Q100 and higher and control lots 18230Q100 and higher, which are the first lots manufactured using the new internal reference standards. The specific performance changes are identified in the letter, dated March 23, 2005, as compared to current product using the previous standards (calibrators lot 05434Q100 and control lot 03071Q100).
- Initiated
- 2005-03-23
- Root cause
- Other
- Terminated
- 2012-01-27
- Distribution
- Nationwide, Puerto Rico, Hawaii, Mexico, Guatemala, Costa Rica, Venezuela, Colombia, Chile, Uruguay, Argentina, Brazil, Dominican Republic, Canada, Germany, Japan , Singapore, India, Taiwan, Thailand, Korea, Australia, Honduras, and Panama,
- Recall number
- Z-0624-06
- Recall status
- Terminated
- CDRH record ID
- 41034
- FDA classified
- 2006-03-15
- Recall event number
- 32890